Artivion (AORT) Asset Writedowns and Impairment (2010 - 2013)

Artivion (AORT) reported Asset Writedowns and Impairment of $3.2 million for Q4 2013, up 841.18% quarter-over-quarter from $340000.0 in Q3 2012.

Artivion (AORT) Asset Writedowns and Impairment (2010 - 2013) Analysis & Trends

Artivion has reported Asset Writedowns and Impairment for 3 years, with the latest figure at $3.2 million in Q4 2013.

  • For the quarter ending Q4 2013, Asset Writedowns and Impairment changed N/A year-over-year to $3.2 million; the trailing twelve-month figure through Dec 2013 stood at $4.5 million (changed N/A YoY), and the FY2021 full-year result was $4.9 million, changed N/A from the prior year.
  • Asset Writedowns and Impairment for Q4 2013 stood at $3.2 million, up from $340000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $3.6 million in Q3 2010, with the low at -$2.7 million in Q4 2010.
  • Historically, Asset Writedowns and Impairment has averaged $1.1 million across 3 years, with a median of $1.8 million in 2012.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Artivion 1.02 Bn 961.48 Mn 75.45 Mn

Historic Data

Download Data
DateValue
Dec 31, 2013 3.20 Mn
Dec 31, 2013 3.20 Mn
Sep 30, 2012 340,000.00
Sep 30, 2012 340,000.00
Dec 31, 2010 -2.72 Mn
Dec 31, 2010 -2.72 Mn
Sep 30, 2010 3.64 Mn
Sep 30, 2010 3.64 Mn